Literature DB >> 12846977

Oxidative modifications of alpha-synuclein.

Harry Ischiropoulos1.   

Abstract

Hallmark lesions of neurodegenerative synucleinopathies contain alpha-synuclein (alpha-syn) that is modified by nitration of tyrosine residues and possibly by dityrosine cross-linking to generated stable oligomers. Data gathered from in vitro experiments and from model systems of cells transfected with wild-type and mutant alpha-syn revealed that conditions resulting in alpha-syn nitration also induce formation of alpha-syn inclusions with similar biochemical characteristics to protein extracted from human lesions. The detection of tyrosine-nitrated alpha-syn signifies the formation of reactive nitrogen species capable of both radical and electrophilic attack on aromatic residues as well as nucleophilic additions and oxidations. The cellular sources and biochemical reactivity of reactive nitrogen species in the central nervous system remain largely unknown, but kinetically fast reactions of nitric oxide with superoxide to form peroxynitrite as well as enzymatic one-electron oxidation of nitrite are two important sources of reactive nitrogen species. Based on these findings a model is proposed where the process of fibrilization can be differentially affected by oxidants and nitrating species. Posttranslational modifications of alpha-syn by reactive nitrogen species inhibits fibril formation and results in urea- and SDS- insoluble, protease-resistant alpha-syn aggregates that maybe responsible for cellular toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846977     DOI: 10.1111/j.1749-6632.2003.tb07466.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  28 in total

Review 1.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

2.  Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.

Authors:  Edward Rockenstein; Kiren Ubhi; Chandra Inglis; Michael Mante; Christina Patrick; Anthony Adame; Eliezer Masliah
Journal:  Neuroreport       Date:  2012-03-07       Impact factor: 1.837

Review 3.  Genetics of Parkinson disease.

Authors:  Nathan Pankratz; Tatiana Foroud
Journal:  NeuroRx       Date:  2004-04

Review 4.  RBR E3-ligases at work.

Authors:  Judith J Smit; Titia K Sixma
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

Review 5.  The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.

Authors:  Makoto Hashimoto; Kohichi Kawahara; Pazit Bar-On; Edward Rockenstein; Leslie Crews; Eliezer Masliah
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

6.  α-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia.

Authors:  Erik Su; Michael J Bell; Stephen R Wisniewski; P David Adelson; Keri L Janesko-Feldman; Rosanne Salonia; Robert S B Clark; Patrick M Kochanek; Valerian E Kagan; Hülya Bayır
Journal:  Dev Neurosci       Date:  2010-12-02       Impact factor: 2.984

7.  Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein.

Authors:  Wai Haung Yu; Yasuji Matsuoka; István Sziráki; Audrey Hashim; John Lafrancois; Henry Sershen; Karen E Duff
Journal:  Neurochem Res       Date:  2007-11-13       Impact factor: 3.996

8.  GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with alpha-synuclein.

Authors:  Andrew O Koob; Amy D Paulino; Eliezer Masliah
Journal:  Neurosci Lett       Date:  2009-11-20       Impact factor: 3.046

9.  Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.

Authors:  Andrew O Koob; Kiren Ubhi; Johan F Paulsson; Jeffery Kelly; Edward Rockenstein; Michael Mante; Anthony Adame; Eliezer Masliah
Journal:  Exp Neurol       Date:  2009-11-26       Impact factor: 5.330

10.  Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy.

Authors:  Kiren Ubhi; Phil Hyu Lee; Anthony Adame; Chandra Inglis; Michael Mante; Edward Rockenstein; Nadia Stefanova; Gregor K Wenning; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2009-09       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.